|
10th ESWI Influenza Conference 2025
When Infections Meet NCDs: The Bidirectional Relationship Between Cardiometabolic Conditions and Respiratory Viruses
Check out this Satellite Symposium organised by the ESWI IDC and supported by IFPMA and Sanofi from ESWI2026.
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
The pooled dataset encompassed 466,320 individually randomized participants, of whom 107,700 (23.1%) had a history of CVD.
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference
It highlights trials on novel therapies, vaccination, blood pressure management, and the use of technology and risk scores to guide treatment.
News
Policy & Recommendations
The EU’s heartfelt pledge to reduce the impact of cardiovascular diseases
Read an interview with Marianne Takki, Head of Unit for Disease Prevention and Health Promotion at the European Commission
Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement
With the contribution of the European Association of Preventive Cardiology (EAPC), the Association for Acute CardioVascular Care (ACVC), and the Heart Failure Association (HFA) of the ESC
News
Policy & Recommendations
EU Cardiovascular Health Plan: Call for Feedback
Cardiovascular diseases remain the leading cause of death in the EU, claiming 1.7 million lives lost each year.
Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized with RSV
Cardiovascular complications contribute to adverse outcomes in patients with influenza and SARS-CoV-2 infections. While the association of RSV infection with cardiovascular events (CVE) has been described, data are limited.
Cardiac Events in Adults Hospitalized for Respiratory Syncytial Virus vs COVID-19 or Influenza
What is the risk of acute cardiovascular complications in adults hospitalized for respiratory syncytial virus (RSV) vs influenza or SARS-CoV-2 Omicron infection?
